Wednesday, 30 September 2026Updated 7m ago

← Top stories

AUROPHARMA

Aurobindo Pharma Limited · ₹1,697.7 +0.0% on 29 Sept · 1M +3.2% · 3M +9.3% · 2 stories in 60 days · 1 positive · 1 negative

Open the company tag: stories, tone, the tags it comes with →

Price and news

NSE daily close · markers = sessions where news first traded

Positive newsNegative newsNeutral

Legal▼Picking up

GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma

GST appellate authority upheld a ₹4.6 crore ITC claim order against Aurobindo Pharma
The order relates to FY2020-21 under the Central GST Act and Telangana GST Act
The tax order adds a compliance overhang for Aurobindo Pharma and Indian pharma investors

Aurobindo Pharma GST Taxes Pharma and healthcare2 sources · 1h

Policy▲Developing · 3

US exempts select Indian specialty drugs and ingredients from its 100% pharma tariff

The exemption covers certain specialty drugs and ingredients from India and 19 other countries
Eligible products include drugs for rare diseases, infertility treatments, cell therapies and gene therapies
Tariff relief supports US-facing specialty-drug sales at Sun Pharma and Aurobindo Pharma

Sun Pharma Aurobindo Pharma US tariffs Pharma and healthcare US drug pricing+17 sources · 14h